Fimasartan Potassium API

Name	Fimasartan potassium
Chinese name	非马沙坦钾
Cas Number	1020110-23-9
Source	India
Qualifications	-/-/-/-/-

Fimasartan was developed by Korea Boryeong Pharmaceutical Co., Ltd. and was launched in South Korea in 2011. It is a new type of non-peptide angiotensin II receptor antagonist. Fimasartan shows rapid growth in many types of hypertension. And effective antihypertensive effect, compared with other sartan drugs such as Losartan and Olmesartan medoxomil, it has a more effective antihypertensive effect. Long-term use of Fimasartan has a better protective effect on heart and kidney function. There are a large number of hypertensive patients in China. The treatment of hypertension requires long-term medication. There are many drugs on the market for hypertension. Many products have a large market capacity. Fimasartan has a good market prospect. The patent of the main patent compound of the original research in China has expired. If Fimasartan can be marketed in China, the dosage of preparations and raw materials will be large, and the profit margins of preparations and raw materials will be good.

Hot Tags: fimasartan potassium api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Letrozole API, Ulipristal Acetate API, Celecoxib API, Escitalopram Oxalate API, Lercanidipine Hydrochloride API, Lifitegrast API

• Previous: Engligliflozin API
• Next: Pallidone Palmitate API